P-GLYCOPROTEIN AND MULTIDRUG RESISTANCE: STRUCTURE-ACTIVITY RELATIONSHIPS OF MODULATORS

被引：17

作者：

Huber, Paula C. ^{[1
]}

Maruiama, Cintia H. ^{[1
]}

Almeida, Wanda P. ^{[1
]}

机构：

[1] Univ Estadual Campinas, Inst Quim, Dept Quim Organ, BR-13084971 Campinas, SP, Brazil

来源：

QUIMICA NOVA | 2010年 / 33卷 / 10期

关键词：

P-glycoprotein; multidrug resistance; modulators; DRUG-RESISTANCE; ABC TRANSPORTER; CELLS; INHIBITORS; BINDING; MODEL; MDR; COMBINATION; MECHANISMS; TARIQUIDAR;

D O I：

10.1590/S0100-40422010001000027

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

P-GLYCOPROTEIN AND MULTIDRUG RESISTANCE: STRUCTURE-ACTIVITY RELATIONSHIPS OF MODULATORS. Multidrug resistance, MDR is a major obstacle for cancer chemotherapy. MDR can be reversed by drugs that vary in their chemical structure and main biological activity. Many efforts have been done to overcome MDR based on studies of structure-activity relationships and in this review we summarize some aspects of MDR mediated by P-glycoprotein (P-gp), as the most experimentally and clinically tested form of drug resistance. The most significant MDR mechanisms revealed until now are shortly discussed. Physicochemical and structural properties of MDR modulators, measures of the MDR reversal, and QSAR studies are included.

引用

页码：2148 / 2154

页数：7

共 50 条

[31] Probing Multidrug Resistance P-glycoprotein Transporter Activity with SPECT Radiopharmaceuticals
Piwnica-Worms, David
Sharma, Vijay
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2010, 10 (17) : 1834 - 1845
[32] Multidrug Resistance Through the Spectacle of P-Glycoprotein
Goda, Katalin
Bacso, Zsolt
Szabo, Gabor
CURRENT CANCER DRUG TARGETS, 2009, 9 (03) : 281 - 297
[33] Inhibition of P-glycoprotein activity and reversal of cancer multidrug resistance by Momordica charantia extract
Limtrakul, P
Khantamat, O
Pintha, K
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 54 (06) : 525 - 530
[34] The P-glycoprotein multidrug transporter
Fardel, O
Lecureur, V
Guillouzo, A
GENERAL PHARMACOLOGY, 1996, 27 (08): : 1283 - 1291
[35] Chalcogenopyrylium dyes as inhibitors/modulators of P-glycoprotein in multidrug-resistant cells
Sawada, Geri A.
Raub, Thomas J.
Higgins, J. William
Brennan, Nancy K.
Moore, Teiah M.
Tombline, Gregory
Detty, Michael R.
BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (22) : 9745 - 9756
[36] An Update on Circumventing Multidrug Resistance in Cancer by Targeting P-Glycoprotein
Yang, Xiaoqian
Li, Xiaoduan
Duan, Zhenfeng
Wang, Xipeng
CURRENT CANCER DRUG TARGETS, 2018, 18 (07) : 677 - 696
[37] The mechanism of action of multidrug-resistance-linked P-glycoprotein
Sauna, ZE
Smith, MM
Müller, M
Kerr, KM
Ambudkar, SV
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 2001, 33 (06) : 481 - 491
[38] Mechanism of multidrug resistance to chemotherapy mediated by P-glycoprotein (Review)
Tian, Yichen
Lei, Yongrong
Wang, Yani
Lai, Jiejuan
Wang, Jianhua
Xia, Feng
INTERNATIONAL JOURNAL OF ONCOLOGY, 2023, 63 (05)
[39] The Mechanism of Action of Multidrug-Resistance-Linked P-Glycoprotein
Zuben E. Sauna
Melissa M. Smith
Marianna Müller
Kathleen M. Kerr
Suresh V. Ambudkar
Journal of Bioenergetics and Biomembranes, 2001, 33 : 481 - 491
[40] Inhibition of P-Glycoprotein Mediated Multidrug Resistance by Stemofoline Derivatives
Umsumarng, Sonthaya
Pintha, Komsak
Pitchakarn, Pornsiri
Sastraruji, Kwankamol
Sastraruji, Thanapat
Ung, Alison T.
Jatisatienr, Araya
Pyne, Stephen G.
Limtrakul, Pornngarm
CHEMICAL & PHARMACEUTICAL BULLETIN, 2013, 61 (04) : 399 - 404

← 1 2 3 4 5 →